Product
Zadaxin
1 clinical trial
1 indication
Indication
HIV-1 infectionClinical trial
A Prospective Single-arm Cohort Study Evaluating the Safety and Efficacy of Thymalfasin (Zadaxin®) in the Treatment of HIV-positive Patients With Immune Reconstitution DisordersStatus: Completed, Estimated PCD: 2022-07-22